Table 2. Patient-level factors associated with rtPA exclusion in a diabetic stroke population.
| P Value | Odds ratio | 95% C.I. | For OR | |
|---|---|---|---|---|
| Lower | Upper | |||
| Age | 0.079 | 1.020 | 0.998 | 1.042 |
| BMI | 0.551 | 1.010 | 0.977 | 1.044 |
| NIH stroke scale | 0.455 | 0.965 | 0.878 | 1.060 |
| Presentation of weakness | 0.001* | 0.233 | 0.096 | 0.567 |
| Altered level of consciousness | 0.563 | 1.202 | 0.645 | 2.241 |
| Aphasia/language disturbance | 0.020* | 0.521 | 0.301 | 0.903 |
| Risk of mortality GWTG | 0.991 | 1.001 | 0.907 | 1.104 |
| Female gender | 0.001* | 2.323 | 1.426 | 3.785 |
| Ethnicity | 0.250 | 1.338 | 0.815 | 2.198 |
| Atrial fibrillation | 0.005* | 2.587 | 1.338 | 5.002 |
| Coronary artery disease | 0.864 | 0.956 | 0.571 | 1.600 |
| Carotid artery stenosis | 0.031* | 3.358 | 1.117 | 10.095 |
| Dyslipidemia | 0.739 | 1.093 | 0.647 | 1.847 |
| Congestive heart failure | 0.818 | 0.925 | 0.476 | 1.798 |
| Hypertension | 0.678 | 0.818 | 0.317 | 2.112 |
| Previous stroke | 0.007* | 1.984 | 1.205 | 3.265 |
| Previous TIA | 0.390 | 0.741 | 0.375 | 1.467 |
| Peripheral vascular disease | 0.701 | 1.177 | 0.513 | 2.698 |
| History of smoking | 0.417 | 0.778 | 0.425 | 1.425 |
| Antiplatelet medication | 0.408 | 0.794 | 0.460 | 1.370 |
| Cholesterol reducer | 0.084 | 0.508 | 0.236 | 1.095 |
| Antihypertensive medication | 0.879 | 0.958 | 0.555 | 1.656 |
| Antidiabetic medication | 0.274 | 0.726 | 0.409 | 1.288 |